banner
Chromogenic substrate 5-bromo-4-chloro-3-indolyl β-D-cellobioside
Inquiry

Cat. No.: X24-02-LY011

Chromogenic substrate 5-bromo-4-chloro-3-indolyl β-D-cellobioside

Synonym: 177966-52-8; X-β-D-Cellobiopyranoside; X β-D-Cellobioside; X-Cellobioside; 5-Bromo-4-chloro-3-indolyl b-D-cellobioside; 5-Bromo-4-chloro-3-indolyl

  • MDL: MFCD00798387
  • CAS Number: 177966-52-8
  • Compound CID: 12001507
img
Product Size
250 mg; 500 mg; 1 g; 2 g
Price
Datasheet
MSDS
Properties
Description
5-Bromo-4-chloro-3-indolyl β-D-cellobioside is a substrate with active compounds and is commonly used in kinetic studies of enzymes.
Molecular Weight
570.8
Molecular Formula
C20H25BrClNO11
Form
Powder
Purity
>99%, determined by HPLC.
Solubility
It is soluble in methanol at a concentration of 1%.
Applications
5-Bromo-4-chloro-3-indolyl β-D-cellobioside can be used for high-throughput screening to detect enzyme activity, which can accelerate the process of drug discovery and biological research.
Safety Information
Personal Protective Equipment
Gloves, Safety glasses, FFP2 or N95 masks
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0